Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development — Stella

Home/Atrial Fibrillation (AF)/Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development

View on ClinicalTrials.gov

Recruiting

Back to Atrial Fibrillation (AF) trials

Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Taiwan

Tri-Service General Hospital, Taipei

Key details

Sponsor

National Defense Medical Center, Taiwan

Enrollment target

~14,726 participants

Started

July 2025

Primary completion

July 2026

Age range

40 Days – 85 Days

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.